BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Treatment
72 results:

  • 1. Extended pelvic lymph node dissection during robotic prostatectomy: antegrade versus retrograde technique.
    Albo G; Gallioli A; Ripa F; De Lorenzis E; Boeri L; Bebi C; Rocchini L; Longo F; Zanetti SP; Turetti M; Piccoli M; Montanari E
    BMC Urol; 2024 Mar; 24(1):64. PubMed ID: 38515053
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The cost-effectiveness of germline BRCA testing-guided olaparib treatment in metastatic castration resistant prostate cancer.
    Teppala S; Scuffham PA; Tuffaha H
    Int J Technol Assess Health Care; 2024 Mar; 40(1):e14. PubMed ID: 38439629
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Safety assessment, radioiodination and preclinical evaluation of antinuclear antibody as novel medication for prostate cancer in mouse xenograft model.
    Nguyen TMC; Hoang LDC; Nguyen TKG; Nguyen TN; Nguyen QC; Nguyen TB; Dang HHQ; Bui VC; Pham TM; Nguyen TT
    Sci Rep; 2023 Oct; 13(1):18753. PubMed ID: 37907691
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Does Boric Acid Inhibit Cell Proliferation on MCF-7 and MDA-MB-231 Cells in Monolayer and Spheroid Cultures by Using Apoptosis Pathways?
    Bayram D; Özgöçmen M; Çelik DA; Sarman E; Sevimli M
    Biol Trace Elem Res; 2024 May; 202(5):2008-2021. PubMed ID: 37572183
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act.
    Janopaul-Naylor JR; Corriher TJ; Switchenko J; Hanasoge S; Esdaille A; Mahal BA; Filson CP; Patel SA
    Cancer Med; 2023 Sep; 12(17):18258-18268. PubMed ID: 37537835
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Development and validation of a clinic machine-learning nomogram for the prediction of risk stratifications of prostate cancer based on functional subsets of peripheral lymphocyte.
    Yang C; Liu Z; Fang Y; Cao X; Xu G; Wang Z; Hu Z; Wang S; Wu X
    J Transl Med; 2023 Jul; 21(1):465. PubMed ID: 37438820
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Oxidative stress induced by Pollonein-LAAO, a new L-amino acid oxidase from Bothrops moojeni venom, prompts prostate tumor spheroid cell death and impairs the cellular invasion process in vitro.
    Polloni L; Costa TR; Morais LP; Borges BC; Teixeira SC; de Melo Fernandes TA; Correia LIV; Bastos LM; Amorim FG; Quinton L; Soares AM; Silva MJB; Ferro EAV; Lopes DS; de Melo Rodrigues Ávila V
    Cell Signal; 2023 Sep; 109():110785. PubMed ID: 37364850
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Enucleation of the prostate as retreatment for recurrent or residual benign prostatic obstruction: a systematic review and a meta-analysis.
    Pyrgidis N; Mykoniatis I; Lusuardi L; Schulz GB; Sokolakis I; Stief C; Sountoulides P
    Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):693-701. PubMed ID: 37193777
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long-term Risks of Depression and Suicide Among Men with prostate cancer: A National Cohort Study.
    Crump C; Stattin P; Brooks JD; Sundquist J; Bill-Axelson A; Edwards AC; Sundquist K; Sieh W
    Eur Urol; 2023 Sep; 84(3):263-272. PubMed ID: 37169640
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma.
    Zhuo X; Dai H; Yu S
    Medicine (Baltimore); 2022 Dec; 101(50):e31290. PubMed ID: 36550819
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Synthesize of Bi
    Moradi A; Abdihaji M; Kouchaksaraie SB; Alkinani TA; Mahmoudi A; Davoudi A; Dashtmiani W; Ghezeljeh SM; Aghajani S; Ghasemian R; Taramsari SM; Majlesi A; Niyaki ZM; Salehzadeh A
    Sci Rep; 2022 Dec; 12(1):21245. PubMed ID: 36482061
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer.
    Ashizawa T; Nagata M; Nakamura S; Hirano H; Nagaya N; Lu Y; Horie S
    Sci Rep; 2022 Oct; 12(1):18016. PubMed ID: 36289357
    [TBL] [Abstract] [Full Text] [Related]  

  • 13.
    Moradi F; Duan H; Song H; Davidzon GA; Chung BI; Thong AEC; Loening AM; Ghanouni P; Sonn G; Iagaru A
    J Nucl Med; 2022 Dec; 63(12):1822-1828. PubMed ID: 35512996
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database.
    Beckmann KR; Bangma CH; Helleman J; Bjartell A; Carroll PR; Morgan T; Nieboer D; Santaolalla A; Trock BJ; Valdagni R; Roobol MJ;
    Prostate; 2022 May; 82(7):876-879. PubMed ID: 35254666
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The comparison of survival between active surveillance or watchful waiting and focal laser ablation in patients with low-risk prostate cancer.
    Li JK; Zhang CC; Qiu S; Jin K; Cai BY; Yuan QM; Xiong XY; Tang LS; Jin D; Zhou XH; Bao YG; Yang L; Wei Q
    Asian J Androl; 2022; 24(5):494-499. PubMed ID: 35102899
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association of β-Blocker Use at Time of Radical prostatectomy With Rate of treatment for prostate cancer Recurrence.
    Sivanesan S; Taskén KA; Grytli HH
    JAMA Netw Open; 2022 Jan; 5(1):e2145230. PubMed ID: 35080602
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Posterior musculofascial reconstruction in robot-assisted laparoscopic prostatectomy for the treatment of clinically localised prostate cancer: a Cochrane Review.
    Rosenberg JE; Jung JH; Lee H; Lee S; Bakker CJ; Dahm P
    BJU Int; 2022 Jul; 130(1):6-17. PubMed ID: 34825456
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic and epigenetic bases of prostate tumor cell radioresistance.
    Kutilin D
    Klin Onkol; 2021; 34(3):220-234. PubMed ID: 34362257
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Oxymestane, a cytostatic steroid derivative of exemestane with greater antitumor activity in non-estrogen-dependent cell lines.
    Pires AS; Varela CL; Marques IA; Abrantes AM; Gonçalves C; Rodrigues T; Matafome P; Botelho MF; Roleira FMF; Tavares-da-Silva E
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105950. PubMed ID: 34271024
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genetic and epigenetic bases of prostate tumor cell radioresistance.
    Kutilin Denis
    Ceska Gynekol; 2021; 86(3):220-234. PubMed ID: 34192880
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.